The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West
Teunissen, L.L.; Notermans, N.C.
Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
1998
ISSN/ISBN: 0028-2162 PMID: 9864517 Document Number: 494780
Document emailed within 1 workday
Related Documents
Biran, N.; Jagannath, S.; Chari, A. 2013: Risk stratification in multiple myeloma, part 1: characterization of high-risk disease Clinical Advances in Hematology and Oncology: H&o 11(8): 489-503Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Dimopoulos, M.A.; Kastritis, E.; Anagnostopoulos, A.; Melakopoulos, I.; Gika, D.; Moulopoulos, L.A.; Bamia, C.; Terpos, E.; Tsionos, K.; Bamias, A. 2006: Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid Haematologica 91(7): 968-971
Togawa, A. 1995: The general management of multiple myeloma--risk factor Nihon Rinsho. Japanese Journal of Clinical Medicine 53(3): 642-646
Braggio, E.; Albarracín Garramuño, F. 2013: Genetic tools for risk-stratification in multiple myeloma Medicina 73(4): 369-375
Al-Mueilo, S.H.; Al-Amri, A.M. 2008: Renal failure in patients with multiple myeloma: a single center experience Saudi Medical Journal 29(3): 466-468
Discalzi, G.; Cioci, I.; Ganio, L.; Ponzetti, C.; Coscia, G. 1991: Multiple myeloma and occupational risk factors: a case-control study La Medicina del Lavoro 82(3): 248-252
Barlogie, B.; Alexanian, R. 1989: Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma Cancer Research 49(24 Pt 1): 7172-7175
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Cristoffanini, A.P.; Vidal, M.A.; Cea, X.; Zapata, C. 1987: Multiple myeloma. Clinical experience of 15 years in the 10th region Revista Medica de Chile 115(11): 1061-1065
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Abe, M. 2006: Bone disease in multiple myeloma and its mechanism Clinical Calcium 16(4): 565
Mohammadi, L.; Harir, N.; Brahimi, M.; Moulessehoul, S.; Bekadja, M.Amine. 2017: Epidemiological, clinical and pronostic aspects of multiple myeloma eligible for therapeutic intensification followed by autologous hematopoietic stem cell in the Algerian West: report of 147 cases La Tunisie Medicale 95(6): 415-421
Kiyoi, H.; Naito, K.; Ohno, R.; Naoe, T. 1996: Comparable gene structure of the immunoglobulin heavy chain variable region between multiple myeloma and normal bone marrow lymphocytes Leukemia 10(11): 1804-1812
Wong, D.F.; Bobechko, P.E.; Becker, E.J.; Howe, G.R. 1981: Coexistent multiple myeloma and Paget's disease of bone Journal of the Canadian Association of Radiologists 32(4): 251-253
Pandit, S.R. 2005: Multiple myeloma: treatment options for an incurable disease Journal of the Association of Physicians of India 53: 1060-1064
Vinciguerra, V.; Anderson, K.; McIntyre, O.R. 1985: Diaziquone for resistant multiple myeloma. Cancer and Leukemia Group B Cancer Treatment Reports 69(3): 331-332
Rosen, L.S.; Gordon, D.; Kaminski, M.; Howell, A.; Belch, A.; Mackey, J.; Apffelstaedt, J.; Hussein, M.; Coleman, R.E.; Reitsma, D.J.; Seaman, J.J.; Chen, B.L.; Ambros, Y. 2001: Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial Cancer Journal 7(5): 377-387